Last Updated: August 9, 2026

Suppliers and packagers for tyzavan


✉ Email this page to a colleague

« Back to Dashboard


tyzavan

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Hikma TYZAVAN vancomycin hydrochloride SOLUTION;INTRAVENOUS 211962 NDA Hikma Pharmaceuticals USA Inc. 0143-9466-06 6 BAG in 1 CARTON (0143-9466-06) / 250 mL in 1 BAG (0143-9466-01) 2025-10-17
Hikma TYZAVAN vancomycin hydrochloride SOLUTION;INTRAVENOUS 211962 NDA Hikma Pharmaceuticals USA Inc. 0143-9467-06 6 BAG in 1 CARTON (0143-9467-06) / 350 mL in 1 BAG (0143-9467-01) 2025-10-17
Hikma TYZAVAN vancomycin hydrochloride SOLUTION;INTRAVENOUS 211962 NDA Hikma Pharmaceuticals USA Inc. 0143-9468-06 6 BAG in 1 CARTON (0143-9468-06) / 150 mL in 1 BAG (0143-9468-01) 2025-10-17
Hikma TYZAVAN vancomycin hydrochloride SOLUTION;INTRAVENOUS 211962 NDA Hikma Pharmaceuticals USA Inc. 0143-9468-12 12 BAG in 1 CARTON (0143-9468-12) / 150 mL in 1 BAG (0143-9468-01) 2025-10-17
Hikma TYZAVAN vancomycin hydrochloride SOLUTION;INTRAVENOUS 211962 NDA Hikma Pharmaceuticals USA Inc. 0143-9469-06 6 BAG in 1 CARTON (0143-9469-06) / 300 mL in 1 BAG (0143-9469-01) 2025-10-17
Hikma TYZAVAN vancomycin hydrochloride SOLUTION;INTRAVENOUS 211962 NDA Hikma Pharmaceuticals USA Inc. 0143-9470-06 6 BAG in 1 CARTON (0143-9470-06) / 400 mL in 1 BAG (0143-9470-01) 2025-10-17
Hikma TYZAVAN vancomycin hydrochloride SOLUTION;INTRAVENOUS 211962 NDA Hikma Pharmaceuticals USA Inc. 0143-9471-06 6 BAG in 1 CARTON (0143-9471-06) / 100 mL in 1 BAG (0143-9471-01) 2025-10-17
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for tyzavan

Last updated: July 6, 2026

TYZAVAN suppliers: Who manufactures, supplies, and distributes the drug in key markets?

Executive summary: No reliable supplier, manufacturer, or distributor dataset is available in the information provided to identify the supply chain for TYZAVAN (API source, contract manufacturers, packaging sites, or commercial distributors). Do not proceed with supplier mapping without confirmed labels, FDA/EMA product listings, or verifiable corporate/manufacturing records.

What company supplies TYZAVAN to pharmacies and wholesalers?

Featured snippet: Supplier/distributor identification for TYZAVAN cannot be produced from the provided inputs.

How to determine the commercial supplier from product labeling

For prescription drugs, the “supplier” question is typically answered from:

  • U.S. Prescribing Information (manufacturer and distributor lines)
  • NDC labeler codes (labeler for the finished dosage form)
  • DSCSA transaction history (license-holder chain)
  • Wholesaler distribution statements tied to the labeled sponsor

No TYZAVAN labeler/manufacturer lines were provided.

Who manufactures TYZAVAN API and finished dosage forms?

Featured snippet: The API and finished-dose manufacturing sites for TYZAVAN cannot be listed from the provided information.

Common manufacturing models that affect “supplier” answers

  • Single-site manufacturer supplying API and finish
  • API supplier + contract finished-dose manufacturer
  • Co-packers for packaging and secondary labeling
  • GxP repackaging under a different labeler

No API/CMO/packager identifiers were supplied.

What is the FDA listing status of TYZAVAN that reveals the manufacturer?

Featured snippet: TYZAVAN FDA listing details that expose the manufacturer and labeler are not available in the provided inputs.

What to look up in FDA datasets

  • NDC Directory (labeler name and submission type)
  • Orange Book (if applicable) to infer the NDA holder and listed patents (finished product manufacturer is often aligned with submission)
  • Drug Registration and Listing System for establishment registration names

No FDA product identifiers (NDC, application number, labeler) were provided.

Is TYZAVAN covered by CDER drug master file (DMF) or API registrations that identify suppliers?

Featured snippet: API registration and DMF-driven supplier mapping for TYZAVAN cannot be produced from the provided inputs.

Why DMFs matter for API supplier identification

  • DMFs often list API manufacturers even when finished dosage manufacturing is performed elsewhere.
  • Without an API name, CAS, DMF holder, or linked FDA reference, supplier identification is not actionable.

How many suppliers are listed for TYZAVAN across NDC labelers and strengths?

Featured snippet: Supplier counts across NDCs cannot be calculated because TYZAVAN NDCs and strengths are not provided.

Typical multi-supplier patterns

  • One labeler per strength
  • Multiple labelers per market packaging configuration
  • Different labelers for private-label or authorized generics

Which CMO/contract manufacturer makes TYZAVAN tablets/capsules/solutions?

Featured snippet: Contract manufacturing identity for TYZAVAN cannot be listed from the provided inputs.

What evidence is required to name a CMO

  • Manufacturing address in FDA labeling
  • Establishment registration match
  • NDA/ANDA site information
  • Inspection histories (EIR) linked to the site

None of these identifiers were provided.

What packaging and distribution suppliers handle TYZAVAN (secondary packaging, kits, cold chain)?

Featured snippet: Packaging and logistics suppliers for TYZAVAN cannot be identified from the provided inputs.

Where packaging suppliers show up

  • NDC labeler vs. “distributed by” split
  • Kit components and packaging lines in labeling
  • DSCSA/labeler records

No TYZAVAN packaging configuration details were provided.

Do TYZAVAN suppliers differ by country or regulator (US vs EU vs UK)?

Featured snippet: Cross-region supplier mapping cannot be produced without country-specific product identifiers.

Regulatory listing differences that change the supplier

  • EMA product registration exposes marketing authorization holder and sometimes manufacturer(s)
  • UK MHRA disclosures can differ from EU naming
  • Local distributors may be the labeled “supplier” for the market even if the manufacturer is offshore

No country/regional product listings were provided.

How to build a litigation-ready TYZAVAN supplier chain of custody

Featured snippet: A defensible supplier chain cannot be built from the provided inputs.

What courts and regulators typically require

  • Labeler/manufacturer names tied to NDC and labeling history
  • Establishment registration numbers
  • Contract manufacturing relationships (assignment/quality agreements)
  • DSCSA license-holder transaction chain

No TYZAVAN identifiers or documentation were provided.

Key Takeaways

  • Supplier identification for TYZAVAN cannot be produced from the provided information.
  • A correct answer requires verifiable product identifiers (NDC, application/labeler, manufacturer line, establishment registration) and regulatory listings or labeling sources.

FAQs

  1. What is the TYZAVAN NDC labeler name?
  2. Who is the TYZAVAN manufacturer of record on the prescribing information?
  3. Which establishment registration numbers are tied to TYZAVAN manufacturing?
  4. Are there multiple TYZAVAN labelers across strengths or dosage forms?
  5. Which distributors sell TYZAVAN through U.S. wholesaler channels?

References

No sources were provided or cited.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.